The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., (Caladrius)(Nasdaq: CLBS), has reached the halfway point for enrollment and treatment.
19-Jul-2017 7:00 AM EDT Add to Favorites
Paper on immunotherapy for head and neck cancer reports favorable results.
16-May-2017 3:30 PM EDT Add to Favorites
Sanford Research scientists recently published a review article in an issue of Stem Cells Translational Medicine focused on the study of and utility of adult-derived stem cells.
22-Feb-2017 11:05 AM EST Add to Favorites
A clinical trial at Sanford Health is studying if an immunotherapy drug developed by Merck might be able to treat certain patients with advanced esophageal cancer. The Merck Keynote 181 trial is now open at Sanford.
31-Jan-2017 2:05 PM EST Add to Favorites
Dr. Alexander Drofa removed clot in 9-day-old baby using unique method
11-Jan-2017 5:05 PM EST Add to Favorites
The first FDA-approved clinical trial of its kind in the United States using a person’s own fat-derived adult stem cells to treat shoulder injuries is available at Sanford Health.
4-Jan-2017 10:05 AM EST Add to Favorites
Sanford Research lab exploring role of protein in disease progression.
20-Dec-2016 1:20 PM EST Add to Favorites
Sequencing tools analyze unique genetic information
10-Oct-2016 4:05 PM EDT Add to Favorites
20-Jun-2016 11:05 AM EDT